Weight-related comorbidity
A weight-linked condition (T2D, hypertension, sleep apnea) that lowers the BMI threshold to 27.
FDA labels allow GLP-1 weight-loss treatment at BMI ≥27 if you have a weight-related comorbidity: type 2 diabetes, high blood pressure, dyslipidemia, obstructive sleep apnea, or prediabetes. Documenting one is central to insurance approval.